<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
#f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff6; src: url("6.ttf"); }
#f1 { font-family:ff6,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.ttf"); }
#f2 { font-family:ff0,serif; font-weight:normal; font-style:normal; }
#f3 { font-family:sans-serif; font-weight:normal; font-style:normal; }
#f4 { font-family:sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff7; src: url("7.ttf"); }
#f5 { font-family:ff7,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff4; src: url("4.ttf"); }
#f6 { font-family:ff4,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff5; src: url("5.ttf"); }
#f7 { font-family:ff5,sans-serif; font-weight:normal; font-style:normal; }
</style>
</head>
<body>
<img id="background" style="position:absolute; left:0px; top:0px;" width="595" height="842" src="page21.png">
<div class="txt" style="position:absolute; left:61px; top:54px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">삼성바이오로직스(207940)</span></div>
<div class="txt" style="position:absolute; left:56px; top:106px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오시밀러 출시는</span></div>
<div class="txt" style="position:absolute; left:56px; top:120px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">오리지널 매출감소에 직격탄</span></div>
<div class="txt" style="position:absolute; left:189px; top:106px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">실제로 베네팔리가 유럽에 출시되면서 Enbrel의 2016년 유럽매출은 19.2억유로에서</span></div>
<div class="txt" style="position:absolute; left:189px; top:121px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">16.7억유로로 전년 대비 13% 감소했다. 이러한 매출감소는 램시마 출시 이후 Remicade</span></div>
<div class="txt" style="position:absolute; left:189px; top:135px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">에서도 나타났다. Remicade를 유럽 시장에서 판매하고 있는 Merck의 Remicade 매출 역</span></div>
<div class="txt" style="position:absolute; left:189px; top:149px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">시 유로화 기준으로 2015년 9.5%, 2016년 29.3% 감소했다. 가격 경쟁력을 갖춘 바이오</span></div>
<div class="txt" style="position:absolute; left:189px; top:163px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">시밀러의 성공적인 시장 안착 가능성을 보여주는 대목이다.</span></div>
<div class="txt" style="position:absolute; left:189px; top:192px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">시장조사기관 Global Data에 따르면 Enbrel의 유럽매출은 2016년부터 2023년까지 연평</span></div>
<div class="txt" style="position:absolute; left:189px; top:206px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">균 13% 감소하는 반면 베네팔리의 매출은 같은 기간 연평균 25.4% 성장할 것으로 전망하</span></div>
<div class="txt" style="position:absolute; left:189px; top:220px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">는 등 베네팔리의 성공 가능성에 무게가 실리고 있다.</span></div>
<div class="txt" style="position:absolute; left:59px; top:248px;"><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">[그림 21] Remicade 유럽시장 매출 추이</span></div>
<div class="txt" style="position:absolute; left:81px; top:264px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(백만유로)</span></div>
<div class="txt" style="position:absolute; left:61px; top:274px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2,000</span></div>
<div class="txt" style="position:absolute; left:61px; top:288px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1,800</span></div>
<div class="txt" style="position:absolute; left:144px; top:268px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">매출액(좌)</span></div>
<div class="txt" style="position:absolute; left:61px; top:302px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1,600</span></div>
<div class="txt" style="position:absolute; left:61px; top:316px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1,400</span></div>
<div class="txt" style="position:absolute; left:61px; top:329px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1,200</span></div>
<div class="txt" style="position:absolute; left:61px; top:343px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1,000</span></div>
<div class="txt" style="position:absolute; left:67px; top:357px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">800</span></div>
<div class="txt" style="position:absolute; left:67px; top:371px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">600</span></div>
<div class="txt" style="position:absolute; left:67px; top:385px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">400</span></div>
<div class="txt" style="position:absolute; left:67px; top:399px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">200</span></div>
<div class="txt" style="position:absolute; left:74px; top:413px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">0</span></div>
<div class="txt" style="position:absolute; left:97px; top:419px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2012</span></div>
<div class="txt" style="position:absolute; left:135px; top:419px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2013</span></div>
<div class="txt" style="position:absolute; left:174px; top:419px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2014</span></div>
<div class="txt" style="position:absolute; left:57px; top:434px;"><span id="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">자료: Global Data, 한국투자증권</span></div>
<div class="txt" style="position:absolute; left:300px; top:248px;"><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">[그림 22] Enbrel/베네팔리 유럽시장 매출액 추이 및 전망</span></div>
<div class="txt" style="position:absolute; left:204px; top:268px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">YoY성장률(우)</span></div>
<div class="txt" style="position:absolute; left:213px; top:284px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">램시마 본격출시</span></div>
<div class="txt" style="position:absolute; left:269px; top:265px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(%)</span></div>
<div class="txt" style="position:absolute; left:282px; top:274px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">10</span></div>
<div class="txt" style="position:absolute; left:282px; top:289px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">5</span></div>
<div class="txt" style="position:absolute; left:282px; top:305px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">0</span></div>
<div class="txt" style="position:absolute; left:282px; top:320px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(5)</span></div>
<div class="txt" style="position:absolute; left:282px; top:336px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(10)</span></div>
<div class="txt" style="position:absolute; left:282px; top:351px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(15)</span></div>
<div class="txt" style="position:absolute; left:282px; top:367px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(20)</span></div>
<div class="txt" style="position:absolute; left:322px; top:265px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(백만유로)</span></div>
<div class="txt" style="position:absolute; left:302px; top:273px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2,500</span></div>
<div class="txt" style="position:absolute; left:382px; top:272px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">엔브렐(좌)</span></div>
<div class="txt" style="position:absolute; left:493px; top:265px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(백만달러)</span></div>
<div class="txt" style="position:absolute; left:453px; top:272px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">베네팔리(우)</span></div>
<div class="txt" style="position:absolute; left:524px; top:273px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">500</span></div>
<div class="txt" style="position:absolute; left:302px; top:300px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2,000</span></div>
<div class="txt" style="position:absolute; left:326px; top:296px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1,803 1,817 </span><span id="f7" style="font-size:6px;vertical-align:super;color:rgba(0,0,0,1);">1,890 1,919</span></div>
<div class="txt" style="position:absolute; left:404px; top:310px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1,668</span></div>
<div class="txt" style="position:absolute; left:479px; top:293px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">414</span></div>
<div class="txt" style="position:absolute; left:459px; top:301px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">389</span></div>
<div class="txt" style="position:absolute; left:441px; top:314px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">337</span></div>
<div class="txt" style="position:absolute; left:502px; top:285px;"><span id="f7" style="font-size:6px;vertical-align:super;color:rgba(0,0,0,1);">443 </span><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">450</span></div>
<div class="txt" style="position:absolute; left:524px; top:300px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">400</span></div>
<div class="txt" style="position:absolute; left:524px; top:314px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">350</span></div>
<div class="txt" style="position:absolute; left:302px; top:328px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1,500</span></div>
<div class="txt" style="position:absolute; left:302px; top:356px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1,000</span></div>
<div class="txt" style="position:absolute; left:424px; top:323px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1,436</span></div>
<div class="txt" style="position:absolute; left:524px; top:328px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">300</span></div>
<div class="txt" style="position:absolute; left:443px; top:333px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1,263</span></div>
<div class="txt" style="position:absolute; left:417px; top:339px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">259</span></div>
<div class="txt" style="position:absolute; left:462px; top:341px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1,112</span></div>
<div class="txt" style="position:absolute; left:524px; top:342px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">250</span></div>
<div class="txt" style="position:absolute; left:485px; top:349px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">978</span></div>
<div class="txt" style="position:absolute; left:504px; top:355px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">859 200</span></div>
<div class="txt" style="position:absolute; left:524px; top:370px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">150</span></div>
<div class="txt" style="position:absolute; left:282px; top:382px;"><span id="f7" style="font-size:6px;vertical-align:super;color:rgba(0,0,0,1);">(25) </span><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">500</span></div>
<div class="txt" style="position:absolute; left:415px; top:383px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">100</span></div>
<div class="txt" style="position:absolute; left:524px; top:383px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">100</span></div>
<div class="txt" style="position:absolute; left:282px; top:397px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(30)</span></div>
<div class="txt" style="position:absolute; left:524px; top:397px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">50</span></div>
<div class="txt" style="position:absolute; left:212px; top:419px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2015</span></div>
<div class="txt" style="position:absolute; left:282px; top:413px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(35)</span></div>
<div class="txt" style="position:absolute; left:251px; top:419px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2016</span></div>
<div class="txt" style="position:absolute; left:314px; top:411px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">0</span></div>
<div class="txt" style="position:absolute; left:524px; top:411px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">0</span></div>
<div class="txt" style="position:absolute; left:327px; top:418px;"><span id="f7" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2012 2013 2014 2015 2016 2017F 2018F 2019F 2020F 2021F</span></div>
<div class="txt" style="position:absolute; left:298px; top:434px;"><span id="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">주: 베네팔리는 한국투자증권 추정치</span></div>
<div class="txt" style="position:absolute; left:298px; top:442px;"><span id="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">자료: Global Data, 한국투자증권</span></div>
<div class="txt" style="position:absolute; left:56px; top:467px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">올해 베네팔리 글로벌 매출</span></div>
<div class="txt" style="position:absolute; left:56px; top:481px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">전년 대비 160% 증가 예상</span></div>
<div class="txt" style="position:absolute; left:189px; top:467px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">우리는 베네팔리가 올해부터 바이오에피스의 매출증가에 본격적으로 기여하기 시작할 것</span></div>
<div class="txt" style="position:absolute; left:189px; top:481px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">으로 전망한다. 바이오에피스는 파트너사인 Biogen이 베네팔리를 판매하면서 발생하는 마</span></div>
<div class="txt" style="position:absolute; left:189px; top:495px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">케팅 등의 비용을 제외한 순이익의 절반 가량을 로열티 매출로 인식하게 된다. 2016년 베</span></div>
<div class="txt" style="position:absolute; left:189px; top:510px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">네팔리 판매로 바이오에피스가 수령한 로열티 매출은 미미했다. 베네팔리가 2016년 유럽</span></div>
<div class="txt" style="position:absolute; left:189px; top:524px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">에서 약 천백억원의 매출을 달성했지만 판매 첫해인 만큼 Biogen의 마케팅비용 부담 역시</span></div>
<div class="txt" style="position:absolute; left:189px; top:538px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">컸을 것으로 예상되기 때문이다. 우리는 올해 베네팔리의 글로벌 매출이 2016년 1억달러</span></div>
<div class="txt" style="position:absolute; left:189px; top:552px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">대비 약 160% 증가한 2억 6천만달러로 추정해 바이오에피스에 인식될 로열티 매출은</span></div>
<div class="txt" style="position:absolute; left:189px; top:566px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">284억원으로 예상한다.</span></div>
<div class="txt" style="position:absolute; left:56px; top:595px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">Biogen 순이익률 가정</span></div>
<div class="txt" style="position:absolute; left:56px; top:609px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">25%~45%</span></div>
<div class="txt" style="position:absolute; left:189px; top:595px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">베네팔리 출시 초기 Biogen의 베네팔리 판매에 따른 순이익률(회계상으로는 영업이익률)</span></div>
<div class="txt" style="position:absolute; left:189px; top:609px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">은 25%로 추정되며 판매가 일정궤도에 오르게 되면 45%의 순이익률도 달성할 것으로 전</span></div>
<div class="txt" style="position:absolute; left:189px; top:623px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">망된다.</span></div>
<div class="txt" style="position:absolute; left:189px; top:652px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오에피스와 Biogen간의 계약내용은 공개되지 않았다. 그러나 셀트리온의 중간 유통채</span></div>
<div class="txt" style="position:absolute; left:189px; top:666px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">널 셀트리온헬스케어가 셀트리온에 이익을 배분해줘야 함에도 불구하고 2014년부터 2016</span></div>
<div class="txt" style="position:absolute; left:189px; top:680px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">년까지 평균 26%의 영업이익률을 시현해 왔다는 점을 감안하면 Biogen이 바이오에피스</span></div>
<div class="txt" style="position:absolute; left:189px; top:694px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">로부터 제품을 직접 공급받아 판매하고 25% 정도의 순이익률을 올리는 데는 무리가 없다</span></div>
<div class="txt" style="position:absolute; left:189px; top:708px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">는 판단이다. 또한 Biogen의 2016년 영업이익률이 약 45% 수준이라는 점을 고려하면 궁</span></div>
<div class="txt" style="position:absolute; left:189px; top:723px;"><span id="f6" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">극적으로 베네팔리 판매에 따른 순이익률도 45% 수준에 달할 가능성이 높다.</span></div>
<div class="txt" style="position:absolute; left:62px; top:801px;"><span id="f3" style="font-size:10px;vertical-align:baseline;color:rgba(127,127,127,1);">20</span></div>
</body>
</html>
